Viewing nowCombinationEmpagazmet Tablet 12.5/1000 Milligrams (Empagliflozin 2L-Proline, Metformin)
Empagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202502978 · Approved 2025.11.18
Improvement of glycemic control in adults with type 2 diabetes
This medication is used to improve blood sugar control in adult patients with type 2 diabetes, in combination with metformin and lifestyle interventions such as diet and exercise. Special caution is necessary for patients with type 2 diabetes who have cardiovascular disease, as they may have an increased risk of cardiovascular events, and consultation with a healthcare professional is recommended. This medication is used to effectively lower blood sugar levels and assist in diabetes management.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the total daily dose of empagliflozin may be increased to 25 mg. Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, sections 4. Adverse Reactions and 6. Interactions). This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, section 3. Patients Requiring Caution, item 1). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this drug immediately (see Precautions for Use, section 2. Patients in Whom This Drug Must Not Be Used, item 2). Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication can cause severe lactic acidosis, so if symptoms related to lactic acidosis occur, discontinue use immediately and seek medical attention. Caution is advised when used in conjunction with other diabetes medications due to the risk of hypoglycemia. Patients with moderate to severe renal impairment or acute kidney problems should not take this medication. In situations that may affect renal function such as acute infections, heart problems, pre- and post-surgery, or dehydration, the use of this medication should be avoided or temporarily discontinued. Pregnant or breastfeeding women should not use this medication, and it is not recommended for children under 18 years of age. This medication may increase the risk of urinary tract infections and genital infections, so quick treatment is necessary if infection symptoms arise. Patients at risk of fluid loss or dehydration should use this medication with caution, particularly elderly patients, who should be closely monitored for hydration status. Regular monitoring is needed as liver function abnormalities or heart function decline may occur during treatment with this medication. There is a risk of hypoglycemia, therefore dose adjustments may be necessary when used with insulin or sulfonylureas. Vitamin B12 deficiency may occur, and it is advisable to check blood Vitamin B12 levels during prolonged use. Alcohol consumption can increase the risk of lactic acidosis, so excessive drinking should be avoided while using this medication. This medication may interact with other drugs; therefore, individuals taking other medications should consult with a physician or pharmacist. In the case of overdose, seek medical care immediately, and blood dialysis may be required. Keep out of reach of children, and store in the original container to maintain quality. Immediately inform healthcare professionals if any unusual symptoms such as fever, pain, or swelling occur around the perineum during treatment with this medication.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, avoid extremely hot or cold places, and storing at room temperature between 1 to 30 degrees Celsius is recommended.
Dark purple oval film-coated tablet
30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.